Kindly refer the attachment

23rd July 2026 The Secretary, The Secretary, BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra-Kurla Dalal Street, Mumbai 400 001 Complex, Bandra East, Mumbai 400 051 Scrip Code: 500674 Symbol: SANOFI Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “Listing Regulations”) Dear Sir/ Madam, Pursuant to Regulation 30 of the Listing Regulations, we would like to inform you that Mr. Rachid Ayari (DIN:10408699) vide his letter dated 22nd July 2026, had conveyed his decision to step down from his current role as the Whole Time Director, Chief Financial Officer and Key Managerial Personnel of the Company with effect from the close of business hours on 30th September 2026, in view of his transition to another role within the Sanofi group. Accordingly, Mr. Rachid Ayari shall cease to be the Whole Time Director, Chief Financial Officer, Key Managerial Personnel and shall also cease to be Senior Management Personnel and member of the Risk Management Committee effective from the close of business hours on 30th September 2026. The Company places on record its sincere appreciation to Mr. Rachid Ayari for his valuable contributions, expert guidance, and dedicated assistance provided during his tenure with the Company. The Company is in the process of identifying a suitable candidate for the position of Chief Financial Officer, who will also be designated as a Key Managerial Personnel. The Company will inform the Stock Exchanges of the appointment in due course. The information required in terms of Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 is enclosed as ‘Annexure-I’ and letter received from Mr. Rachid Ayari is enclosed as ‘Annexure – II’. Thanking you, Yours faithfully, For Sanofi India Limited Haresh Vala Company Secretary and Compliance Officer Membership No.: A18246 Encl: a/a Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com Annexure – I Information as required under Regulation 30 read with Schedule III of the Listing Regulations Particulars Details Mr. Rachid Ayari, Whole Time Director, Chief Financial Officer and Key Managerial Personnel of Reason for change viz. the Company, will step down from his current role, appointment, re- 1. with effect from the close of business hours on appointment, resignation, 30th September 2026 in view of his transition to removal, death or otherwise; another role within the Sanofi group. Date of appointment / re- appointment / cessation (as With effect from the close of business hours on applicable) & term of 30th September 2026 appointment; Brief profile (in case of 3. Not Applicable appointment) Disclosure of relationships 4. between directors (in case of Not Applicable appointment of a director) Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: igrc.sil@sanofi.com Annexure – II 22nd July 2026 The Board of Directors